Want to join the conversation?
Roxanne Meyer with MKM Partners asks about AUR as a lever in 2H16, either through pricing or mix in Bath & Body Works. $LB said AUR has been a strong driver of growth in sales both for spring 2016 and for the past couple of years. Some of that is driven by mix in business. One of the key levers is constant innovation and investment into newness.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?